MOLLY RODRICK: Open Payments
NPI 1497443089 · CASPER, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 23 payments from 9 companies in 2025. Trend: 2023 $1,183 · 2024 $1,509 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $145 |
| ABBVIE INC. | 7 | $129 |
| Phathom Pharmaceuticals, Inc. | 2 | $90 |
| Janssen Biotech, Inc. | 3 | $83 |
| Lilly USA, LLC | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $24 |
| Intercept Pharmaceuticals, Inc. | 1 | $19 |
| Madrigal Pharmaceuticals | 1 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: ENTYVIO, VOQUEZNA, TREMFYA, LINZESS, RINVOQ, SKYRIZI, OMVOH, CREON.
Industry payments across WY — which companies pay providers there.
